Associated Papers
Identification of an optimal mutant allele frequency to detect activating KRAS, NRAS, and BRAF mutations in a commercial cell-free DNA next-generation sequencing assay in colorectal and pancreatic adenocarcinomas.
Caughey BA et al.
Journal of Gastrointestinal Oncology, 2023
Time series analysis of TP53 gene mutations in recurrent HPV-negative vulvar squamous cell carcinoma.
Regauer S et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc, 2019
RNF43 Is an Early and Specific Mutated Gene in the Serrated Pathway, With Increased Frequency in Traditional Serrated Adenoma and Its Associated Malignancy.
Tsai JH et al.
The American Journal of Surgical Pathology, 2016
Targeted next generation sequencing of parotid gland cancer uncovers genetic heterogeneity.
Grünewald I et al.
Oncotarget, 2015
26053092 (PubMed )
Supplement: oncotarget-06-18224-s001.pdf
Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification.
Ng CK et al.
Genome Biology, 2015
Select a paper to view details